Prof. Mark Bartholomä

Prof. Mark Bartholomä, PhD, joined Saarland university faculty since 2018, Heading the Preclinical Radiopharmacy and Research group at department of Radiochemistry Saarland University Medical Center in Homburg, Germany. Mark obtained his PhD in Inorganic Chemistry from the same university, and later followed his research in Nuclear Medicine at Syracuse University, NYC, USA, and Harvard Medical School, Boston, USA. Prof. Bartholomä, is author or co-author of over 122 publication and his work is sited up to date over 650 instances. Prof. Bartholomä is an authority in nuclear medicine development using radioisotopes, specifically in radioligands with Zr-89.